About Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency is a rare disease catalogued by Orphanet (ORPHA:314637). It is associated with the MTO1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency trials.
Search ClinicalTrials.gov for "Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency" or filter by Orphanet code ORPHA:314637 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency. Updated daily.